Rapport Therapeutics (RAPP) Receivables (2026)
Rapport Therapeutics (RAPP) posted quarterly Receivables of $58000.0 for Q1 2026.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Receivables (2026) Analysis & Trends
Rapport Therapeutics (RAPP) has reported Receivables for 1 consecutive years, with $58000.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Rapport Therapeutics | 2.21 Bn | 2.21 Bn | - | 300,000.00 |